Sphingolipids in Multiple Sclerosis
- 513 Downloads
Multiple sclerosis (MS) is a chronic autoimmune demyelinating disease of the CNS. Oligodendrocytes, the myelin-forming cells of the central nervous system (CNS), are target cells in MS. Although the etiology of MS is poorly known, new insights suggest oligodendrocyte apoptosis as one of the critical events followed by glial activation and infiltration of lymphocytes and macrophages. A major breakthrough in delineation of the mechanism of cell death, perivascular cuffing, and glial activation came from elucidation of the sphingolipid signal transduction pathway. The sphingolipid signal transduction pathway induces apoptosis, differentiation, proliferation, and growth arrest depending upon cell and receptor types, and downstream targets. Sphingomyelin, a major component of myelin membrane formed by mature oligodendrocytes, is abundant in the CNS and ceramide, its primary catabolic product released by activation of either neutral or acidic sphingomyelinase, serves as a potential lipid second messenger or mediator molecule modulating diverse cellular signaling pathways. Similarly, under certain conditions, sphingosine produced from ceramide by ceramidase is phosphorylated by sphingosine kinases to sphingosine-1 phosphate, another potent second messenger molecule. Both ceramide and sphingosine-1 phosphate regulate life and death of many cell types including brain cells and participate in pathogenic processes of MS. In this review, we have made an honest attempt to compile recent findings made by others and us relating to the role of sphingolipids in the disease process of MS.
KeywordsSphingomyelinases Ceramide Sphingosine-1 phosphate Signal transduction Oligodendroglial apoptosis Glial activation Perivascular cuffing
This work was supported by grants from National Institutes of Health (NS39940 and NS39940-10S1).
- Dittel, B. N. (2000). Evidence that Fas and FasL contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Archivum Immunologiae et Therapiae Experimentali (Warsz), 48, 381–388.Google Scholar
- Grassme, H., Jendrossek, V., Bock, J., Riehle, A., Gulbins, E., et al. (2002b). Ceramide-rich membrane rafts mediate CD40 clustering. Journal of Immunology, 168, 298–307.Google Scholar
- Marusic, S., Thakker, P., Pelker, J. W., Stedman, N. L., Lee, K. L., McKew, J. C., et al. (2008). Blockade of cytosolic phospholipase A2 alpha prevents experimental autoimmune encephalomyelitis and diminishes development of Th1 and Th17 responses. Journal of Neuroimmunology, 204, 29–37.CrossRefPubMedGoogle Scholar
- Tani, M., Glabinski, A. R., Tuohy, V. K., Stoler, M. H., Estes, M. L., & Ransohoff, R. M. (1996). In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis. American Journal of Pathology, 148, 889–896.PubMedGoogle Scholar